CLASS I Device recall · Reported 28 Feb 2018 · FDA Enforcement Report

Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) recalled

Medtronic Inc., Cardiac Rhythm and Heart Failure (Crhf) is recalling Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Compia MRI, distributed nationwide in the US. The recall was initiated on 19 Dec 2017 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesa. Product No. DTMC1D1: UDI 00643169705807 (Serial No. RPW200289H); b. Product No. DTMC1QQ: UDI 00643169565272 (Serial No. RPL201034H) (EXPANSION: Serial No. RPL200052H, RPL200534H, RPL201039H, RPL201059H, RPL201235H, RPL201236H, RPL201454H, RPL201645H, RPL201664H, RPL201234H)
Quantity recalled951 devices total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0583-2018
FDA event ID
78888
Classification
Class I
Status
Terminated
Recall initiated
19 Dec 2017
FDA classified
19 Apr 2018
Reported
28 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Other
Reason category
Other Reasons

Timeline

19 Dec 2017Recall initiated by company
28 Feb 2018Published in enforcement report+71 days
19 Apr 2018Classified by FDA+50 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D).

Product as listed by the FDA

Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Compia MRI. Labeled as the following: a. Compia MRI CRT-D DF1 (Product No. DTMC1D1); b. Compia MRI Quad CRT-D DF4 (Product No.DTMC1QQ ) Implantable devices that automatically detect and treat episodes of ventricular fibrillation, ventricular tachycardia, fast ventricular tachycardia, and bradyarrhythmia. Some devices can also provide resynchronization therapy, including sequential biventricular pacing (CRT-D devices).

Where it was distributed

US Nationwide Distribution.

Nationwide

Questions about this recall

Why was it recalled?

Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D).

Which lots are affected?

a. Product No. DTMC1D1: UDI 00643169705807 (Serial No. RPW200289H); b. Product No. DTMC1QQ: UDI 00643169565272 (Serial No. RPL201034H) (EXPANSION: Serial No. RPL200052H, RPL200534H, RPL201039H, RPL201059H, RPL201235H, RPL201236H, RPL201454H, RPL201645H, RPL201664H, RPL201234H)

Where was it sold?

US Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 78888

This product is part of a recall event; the main page for the event is Implantable Cardioverter Defibrillators (ICDs), Evera MRI recalled.

More recalls from Medtronic Inc., Cardiac Rhythm and Heart Failure (Crhf)

All 136

Other Pacemakers & Defibrillators recalls

All 494